These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34134738)

  • 21. Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment.
    Chawana TD; Gandhi M; Nathoo K; Ngara B; Louie A; Horng H; Katzenstein D; Metcalfe J; Nhachi CFB;
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):55-59. PubMed ID: 28520618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A group-based mental health intervention for young people living with HIV in Tanzania: results of a pilot individually randomized group treatment trial.
    Dow DE; Mmbaga BT; Gallis JA; Turner EL; Gandhi M; Cunningham CK; O'Donnell KE
    BMC Public Health; 2020 Sep; 20(1):1358. PubMed ID: 32887558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recruitment of Youth Living With HIV to Optimize Adherence and Virologic Suppression: Testing the Design of Technology-Based Community Health Nursing to Improve Antiretroviral Therapy (ART) Clinical Trials.
    Agwu AL; Yusuf HE; D'Angelo L; Rathore M; Marchesi J; Rowell J; Smith R; Toppins J; Trexler C; Carr R; Johnson B; Selden AK; Mahmoudi S; Black S; Guadamuz J; Huettner S; Trent M
    JMIR Res Protoc; 2020 Dec; 9(12):e23480. PubMed ID: 33306036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: The PEBRA cluster-randomized trial.
    Kopo M; Lejone TI; Tschumi N; Glass TR; Kao M; Brown JA; Seiler O; Muhairwe J; Moletsane N; Labhardt ND; Amstutz A
    PLoS Med; 2023 Jan; 20(1):e1004150. PubMed ID: 36595523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.
    Kehoe K; Boulle A; Tsondai PR; Euvrard J; Davies MA; Cornell M
    J Int AIDS Soc; 2020 May; 23(5):e25476. PubMed ID: 32406983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of community- versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: Findings from a pragmatic randomized controlled trial in South Africa.
    Hanrahan CF; Schwartz SR; Mudavanhu M; West NS; Mutunga L; Keyser V; Bassett J; Van Rie A
    PLoS Med; 2019 May; 16(5):e1002808. PubMed ID: 31112543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a Peer-Led Intervention on HIV Care Continuum Outcomes Among Contacts of Children, Adolescents, and Young Adults Living With HIV in Zimbabwe.
    Tapera T; Willis N; Madzeke K; Napei T; Mawodzeke M; Chamoko S; Mutsinze A; Zvirawa T; Dupwa B; Mangombe A; Chimwaza A; Makoni TM; Mandewo W; Senkoro M; Owiti P; Tripathy JP; Kumar AMV
    Glob Health Sci Pract; 2019 Dec; 7(4):575-584. PubMed ID: 31852741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe.
    Makadzange AT; Higgins-Biddle M; Chimukangara B; Birri R; Gordon M; Mahlanza T; McHugh G; van Dijk JH; Bwakura-Dangarembizi M; Ndung'u T; Masimirembwa C; Phelps B; Amzel A; Ojikutu BO; Walker BD; Ndhlovu CE
    PLoS One; 2015; 10(12):e0144057. PubMed ID: 26658814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.
    Agwu AL; Warshaw MG; McFarland EJ; Siberry GK; Melvin AJ; Wiznia AA; Fairlie L; Boyd S; Harding P; Spiegel HML; Abrams EJ; Carey VJ;
    PLoS One; 2017; 12(6):e0178075. PubMed ID: 28604824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
    Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
    PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for HIV virological non-suppression among adolescents with common mental disorder symptoms in Zimbabwe: a cross-sectional study.
    Simms V; Bernays S; Chibanda D; Chinoda S; Mutsinze A; Beji-Chauke R; Mugurungi O; Apollo T; Sithole D; Verhey R; Weiss HA; Willis N
    J Int AIDS Soc; 2021 Aug; 24(8):e25773. PubMed ID: 34402199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy.
    Kouamou V; Manasa J; Katzenstein D; McGregor AM; Ndhlovu CE; Makadzange AT
    AIDS; 2019 Sep; 33(11):1729-1737. PubMed ID: 31361272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
    Moore CL; Turkova A; Mujuru H; Kekitiinwa A; Lugemwa A; Kityo CM; Barlow-Mosha LN; Cressey TR; Violari A; Variava E; Cotton MF; Archary M; Compagnucci A; Puthanakit T; Behuhuma O; Saϊdi Y; Hakim J; Amuge P; Atwine L; Musiime V; Burger DM; Shakeshaft C; Giaquinto C; Rojo P; Gibb DM; Ford D;
    BMC Infect Dis; 2021 Jan; 21(1):5. PubMed ID: 33446115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of detectable viral load in a cohort of HIV-positive adolescents on antiretroviral therapy in South Africa.
    Sher R; Dlamini S; Muloiwa R
    J Int AIDS Soc; 2020 Mar; 23(3):e25474. PubMed ID: 32180367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.
    Zaniewski E; Dao Ostinelli CH; Chammartin F; Maxwell N; Davies MA; Euvrard J; van Dijk J; Bosomprah S; Phiri S; Tanser F; Sipambo N; Muhairwe J; Fatti G; Prozesky H; Wood R; Ford N; Fox MP; Egger M
    J Int AIDS Soc; 2020 Jul; 23(7):e25546. PubMed ID: 32640106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community Based Antiretroviral Treatment in Rural Zimbabwe.
    Chimukangara B; Manasa J; Mitchell R; Nyabadza G; Katzenstein D; Masimirembwa C
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1185-1191. PubMed ID: 28899102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of community adolescent treatment supporters (CATS) interventions in improving linkage and retention in care, adherence to ART and psychosocial well-being: a randomised trial among adolescents living with HIV in rural Zimbabwe.
    Willis N; Milanzi A; Mawodzeke M; Dziwa C; Armstrong A; Yekeye I; Mtshali P; James V
    BMC Public Health; 2019 Jan; 19(1):117. PubMed ID: 30691425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial.
    Chang LW; Kagaayi J; Nakigozi G; Ssempijja V; Packer AH; Serwadda D; Quinn TC; Gray RH; Bollinger RC; Reynolds SJ
    PLoS One; 2010 Jun; 5(6):e10923. PubMed ID: 20532194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A targeted approach for routine viral load monitoring in Malawian adults on antiretroviral therapy.
    Mungwira RG; Divala TH; Nyirenda OM; Kanjala M; Muwalo F; Mkandawire FA; Choko A; Taylor TE; Mallewa J; van Oosterhout JJ; Laufer MK; Laurens MB
    Trop Med Int Health; 2018 May; 23(5):526-532. PubMed ID: 29505108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted combination prevention to support female sex workers in Zimbabwe accessing and adhering to antiretrovirals for treatment and prevention of HIV (SAPPH-IRe): a cluster-randomised trial.
    Cowan FM; Davey C; Fearon E; Mushati P; Dirawo J; Chabata S; Cambiano V; Napierala S; Hanisch D; Wong-Gruenwald R; Masuka N; Mabugo T; Hatzold K; Mugurungi O; Busza J; Phillips A; Hargreaves JR
    Lancet HIV; 2018 Aug; 5(8):e417-e426. PubMed ID: 30030134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.